Pfizer is fighting back against a report that it hid the potential of a blockbuster drug to prevent Alzheimer’s disease in order to avoid shelling out for a “costly clinical trial.” Researchers at Pfizer in 2015 found that Enbrel, an anti-inflammatory drug used to treat rheumatioid arthritis, seemed to reduce the risk of Alzheimer’s disease...
